Enhancing ribociclib administration in patients with breast cancer and brain metastases through a physiologically based pharmacokinetic approach - Top-Institutions - MDSpire

Enhancing ribociclib administration in patients with breast cancer and brain metastases through a physiologically based pharmacokinetic approach

  • By

  • Chao Zhang

  • Shan Li

  • Jiawei Ren

  • Xiaohui Wen

  • January 13, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Neuro-Oncology
    • Pharmacokinetics

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Neuro-Oncology
    • Pharmacology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Neuro-Oncology
    • Pharmacokinetics

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neuro-Oncology
    • Pharmacology
    • Breast Cancer

Original Source(s)

Enhancing ribociclib administration in patients with breast cancer and brain metastases through a physiologically based pharmacokinetic approach

  • by Chao Zhang, Shan Li, Jiawei Ren, Xiaohui Wen

  • January 13, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship